Pancreatic Cancer Research

ResearcherOsaka International Cancer InstituteNo recent work listed

Sachiko Tanaka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8176-1789; OpenAlex author ID A5044398062. Sources: OpenAlex.

Their work

Papers
9 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2012: 2 papers · 2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 9

  1. Main pancreatic duct dilatation and pancreatic cysts in relatives and spouses of patients with pancreatic cancer. First author DOI 10.1371/journal.pone.0280403↗
  2. Predictive Factors for Pancreatic Cancer and Its Early Detection Using Special Pancreatic Ultrasonography in High-Risk Individuals. Co-author DOI 10.3390/cancers13030502↗
  3. Effectiveness of Contrast-Enhanced Ultrasonography for the Characterization of Small and Early Stage Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.ultrasmedbio.2020.04.016↗
  4. A case of stage IA pancreatic ductal adenocarcinoma accompanied with focal pancreatitis demonstrated by contrast-enhanced ultrasonography. First author DOI 10.1007/s10396-018-0870-5↗
  5. The Role of Transabdominal Ultrasound in the Diagnosis of Early Stage Pancreatic Cancer: Review and Single-Center Experience. First author DOI 10.3390/diagnostics9010002↗
  6. Risk of peritoneal carcinomatosis by endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer. Co-author DOI 10.1007/s00535-012-0693-x↗
  7. Safety and effectiveness of gemcitabine in 855 patients with pancreatic cancer under Japanese clinical practice based on post-marketing surveillance in Japan. Co-author DOI 10.1093/jjco/hys211↗
  8. [Discussion meeting on is it possible to detect pancreatic cancer in early stage?]. Last author DOI 10.2169/naika.101.120↗
  9. Diagnostic clues and subsequent examinations that detected small pancreatic cancer. Co-author DOI 10.5754/hge12213↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Junko Fukuda · 5 shared papers, 2018–2023 · strength 0.57
  2. Kenji Ikezawa · 5 shared papers, 2013–2023 · strength 0.52
  3. Kazuyoshi Ohkawa · 5 shared papers, 2013–2023 · strength 0.52
  4. Tatsuya Ioka · 7 shared papers, 2012–2021 · strength 0.48
  5. Kazuhiro Katayama · 4 shared papers, 2018–2021 · strength 0.37
  6. Reiko Ashida · 4 shared papers, 2013–2021 · strength 0.34
  7. Shigenori Nagata · 3 shared papers, 2018–2021 · strength 0.29
  8. Nobuyasu Fukutake · 2 shared papers, 2013–2021 · strength 0.14
  9. Takuo Yamai · 1 shared paper, 2021 · strength 0.11
  10. Ryoji Takada · 1 shared paper, 2021 · strength 0.11
  11. Hidenori Takahashi · 1 shared paper, 2021 · strength 0.11
  12. Kazuhiro Katayama · 3 shared papers, 2012–2013 · strength 0.10
  13. Hisashi Taniai · 1 shared paper, 2013 · strength 0.04
  14. Minoru Tada · 1 shared paper, 2012 · strength 0.04
  15. Tooru Shimosegawa · 1 shared paper, 2012 · strength 0.04
  16. Keiji Hanada · 1 shared paper, 2012 · strength 0.04
  17. Osamu Ishikawa · 1 shared paper, 2013 · strength 0.03
  18. Arata Sakai · 1 shared paper, 2013 · strength 0.03
  19. Natsuko Kawada · 1 shared paper, 2012 · strength 0.03
  20. Osamu Ishikawa · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.